Valeant Pharmaceuticals Completes Sale Of Dendreon To Sanpower Group

Industry Reports
Typography

Valeant Pharmaceuticals International, Inc. announced that its affiliate has completed the sale of all of the outstanding equity interests in its former subsidiary Dendreon Pharmaceuticals LLC to the Sanpower Group, Co., Ltd. , for $819.9 million in cash.

Valeant will use net proceeds from the sale to permanently repay term loan debt under its Senior Credit Facility.

With the closing of this transaction, the Company reiterates its expectation to pay down $5 billion in debt from divestiture proceeds and free cash flow within 18 months of August 2016.

"We continue to deliver on our commitments to reduce debt and simplify our portfolio, while focusing resources on our core businesses," said Joseph C. Papa, chairman and CEO, Valeant. "The proceeds from this sale along with the recently announced sale of the iNova business move us closer to paying down $5 billion of debt from divestitures and free cash flow, and we are confident we will meet and potentially exceed this commitment."

The Company estimates that the expected revenue and Adjusted EBITDA (non-GAAP) from the Dendreon business in the second half of 2017 would have been approximately $170 million and $65 million, respectively.

Established in 1993, the Sanpower Group has become one of the largest, private conglomerates in China. Headquartered in Nanjing, it offers a global platform for its three primary sectors: Healthcare, Retail and Financial Services.

About Valeant 
Valeant Pharmaceuticals International, Inc. is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, gastrointestinal disorders, eye health, neurology and branded generics. More information about Valeant can be found at www.valeant.com.

Arthur Shannon
This email address is being protected from spambots. You need JavaScript enabled to view it.
514-856-3855
877-281-6642 

Elif McDonald
This email address is being protected from spambots. You need JavaScript enabled to view it.
514-856-3855 
877-281-6642 (toll free)

Media Contact:
Lainie Keller
This email address is being protected from spambots. You need JavaScript enabled to view it.
908-927-0617

Market Movers

Rogers Corporation

NYQ : ROG - 20 Jul, 4:02pm
118.27
+0.39 (+0.33%) After Hours:
Open 117.51 Mktcap 2.14B
High 118.33 52wk Hight 118.33
Low 116.08 52wk Low 51.98
Vol 86814 Avg Vol 130654
Eps 5.33 P/e 35.79
Currency: USD

Banco Santander, S.A. Sponsored

NYQ : SAN - 20 Jul, 4:03pm
6.67
+0.12 (+1.83%) After Hours:
Open 6.64 Mktcap 97.25B
High 6.69 52wk Hight 6.99
Low 6.62 52wk Low 3.89
Vol 5.35M Avg Vol 8.03M
Eps 0.49 P/e 13.90
Currency: USD

Merck & Company, Inc. (new)

NYQ : MRK - 20 Jul, 4:00pm
62.94
+0.32 (+0.51%) After Hours:
Open 62.91 Mktcap 172.15B
High 63.24 52wk Hight 66.80
Low 62.85 52wk Low 57.18
Vol 6.65M Avg Vol 8.94M
Eps 3.85 P/e 40.11
Currency: USD

Johnson & Johnson

NYQ : JNJ - 20 Jul, 4:01pm
136.57
+1.36 (+1.01%) After Hours:
Open 135.73 Mktcap 367.90B
High 137.08 52wk Hight 137.08
Low 135.62 52wk Low 109.32
Vol 6.09M Avg Vol 5.61M
Eps 7.16 P/e 22.96
Currency: USD

Pfizer, Inc.

NYQ : PFE - 20 Jul, 4:00pm
33.54
-0.08 (-0.24%) After Hours:
Open 33.47 Mktcap 200.16B
High 33.70 52wk Hight 37.39
Low 33.33 52wk Low 29.83
Vol 16.95M Avg Vol 20.64M
Eps 2.55 P/e 28.23
Currency: USD

Direxion Daily 10-Yr Treasury B

PCX : TYO - 20 Jul, 3:59pm
13.90
-0.06 (-0.43%) After Hours:
Open 13.94 Mktcap
High 13.94 52wk Hight 16.29
Low 13.86 52wk Low 12.63
Vol 3822 Avg Vol 6108
Eps P/e
Currency: USD
Sign up via our free email subscription service to receive notifications when new information is available.
captcha